Inovio Pharmaceuticals (INO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Inovio Pharmaceuticals (INO) is Neutral.

The composite score behind that read is -0.18, weighing +0.00 of bullish evidence against -0.40 bearish.

Inovio Pharmaceuticals last closed at $1.15, +5.50% on the session.

Against the IVW growth benchmark the position is +4.70% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for INO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Inovio Pharmaceuticals in the 1st percentile on return on equity, where 100 is best.

Inovio Pharmaceuticals is classified under Health Care / Biotechnology, with a market capitalisation of $112.70M.

StockMap tracks Inovio Pharmaceuticals as the 278th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Inovio Pharmaceuticals ranks 303rd of 381 in the group, against a group median of -0.08.